시장보고서
상품코드
1651978

세계의 수면장애 시장 : 규모, 점유율, 동향, 업계 분석(증상별, 제품별, 최종사용자별, 지역별), 예측(2025-2034년)

Sleep Disorders Market Size, Share, Trends, Industry Analysis Report: By Disorder, Product, End User, and Region - Market Forecast, 2025-2034

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 118 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최근 조사에 따르면 수면장애 시장 규모는 2034년까지 665억 5,000만 달러에 이를 것으로 예상됩니다. 이 보고서는 현재 시장 역학을 상세하게 통찰하고 미래 시장 성장에 대한 분석을 제공합니다.

불면증, 수면 무호흡 증후군, 나르코렙시 등의 증상의 유병률 증가와 건강 전반에 걸친 수면의 중요성에 대한 의식 증가가 수면장애 시장 수요를 촉진하고 있습니다. 기타 주요 촉진요인으로는 세계 고령화 인구 증가, 비만 등 병존 질환의 높은 비율, 수면 부족의 악영향에 대한 의식 증가 등이 있습니다. 시장 기회로는 웨어러블 장치 및 가정용 진단 도구를 채택함과 동시에 원격 의료 및 원격 환자 모니터링의 확대가 포함됩니다. 불면증 인지 행동 치료(CBT-I)를 포함한 비 약수처리로의 전환과 수면 관리에서 AI 통합과 같은 수면장애 시장 동향은 시장 확대에 더욱 기여하고 있습니다. 이러한 진보로 인해 특히 의료에 대한 액세스가 개선되고 있는 신흥 지역에서 시장은 지속적인 성장을 이루는 태세가 갖추어지고 있습니다.

수면장애 시장 : 분석 개요

불면증 분야는 세계적으로 유병률이 높기 때문에 수면장애 시장에서 수익 기준으로 최대 점유율을 차지하고 있습니다. 그러나 수면 무호흡 증후군의 분야는 특히 비만률이 증가함에 따라 진단과 치료의 도입이 증가하고 있기 때문에 가장 높은 성장률을 나타낼 것으로 예상됩니다.

제품별로는 정확하고 조기 발견의 필요성으로 진단 분야가 시장을 독점하고 있지만, 치료 분야는 CPAP 요법, 웨어러블 디바이스, 비약물 요법의 기술 혁신에 추진되어 높은 성장률을 나타내고 있습니다.

최종 사용자별로는 복잡한 수면장애의 진단과 치료에 있어서의 역할이 확립되어 있기 때문에 병원 및 수면검사실 분야가 큰 점유율을 차지하고 있습니다. 반면 편리한 가정용 의료 솔루션에 대한 수요가 증가함에 따라 가정용 의료 분야가 가장 빠르게 성장하고 있습니다.

북미는 첨단 의료 인프라와 높은 수면장애 진단률에 견인되어 수면장애 시장 점유율을 이끌고 있습니다. 아시아태평양은 의료 접근성 향상, 인지도 향상 및 인구 고령화로 인해 가장 빠르게 성장하고 있습니다.

목차

제1장 서론

제2장 주요 요약

제3장 분석 방법

제4장 수면장애시장 인사이트

  • 시장 현황
  • 수면장애 시장 역학
    • 성장 촉진요인과 기회
      • 수면장애의 진단 및 치료에 있어서의 원격 의료의 도입 증가
      • 웨어러블 수면 모니터링 디바이스의 진보
    • 억제요인과 과제
      • 고액의 치료비
  • PESTLE 분석
  • 수면장애시장 : 용도별 경향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 수면장애 시장 : 증상별

  • 주요 조사 결과
  • 소개
  • 무즈무즈 다리 증후군
  • 나루코렙시
  • 불면증
  • 수면시 무호흡증후군

제6장 세계의 수면장애 시장 : 제품별

  • 주요 조사 결과
  • 소개
  • 진단
  • 치료

제7장 세계의 수면장애 시장 : 최종 사용자별

  • 주요 조사 결과
  • 소개
  • 병원,수면 연구실
  • 재택치료

제8장 세계의 수면장애시장 : 지역별

  • 주요 조사 결과
  • 소개
    • 수면장애 시장의 평가 : 지역별(2020-2034년)
  • 북미
    • 북미 : 증상별(2020-2034년)
    • 북미 : 제품별(2020-2034년)
    • 북미 : 최종사용자별(2020-2034년)
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 증상별(2020-2034년)
    • 유럽 : 제품별(2020-2034년)
    • 유럽 : 최종사용자별(2020-2034년)
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양: 증상별(2020-2034년)
    • 아시아태평양: 제품별(2020-2034년)
    • 아시아태평양: 최종 사용자별(2020-2034년)
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카 : 증상별(2020-2034년)
    • 중동 및 아프리카 : 제품별(2020-2034년)
    • 중동 및 아프리카 : 최종사용자별(2020-2034년)
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카 : 증상별(2020-2034년)
    • 라틴아메리카 : 제품별(2020-2034년)
    • 라틴아메리카 : 최종사용자별(2020-2034년)
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 사업 확대 및 기업 인수 분석
    • 사업 확대
    • 기업 인수
  • 제휴,협업,합의,공개

제10장 기업 프로파일

  • ResMed
  • Philips Healthcare
  • Medtronic
  • Fisher & Paykel Healthcare
  • Somnomed
  • Sleep Number Corporation
  • Invacare Corporation
  • Nihon Kohden Corporation
  • CareFusion
  • Becton Dickinson
  • Circadia
  • Inogen
  • Itamar Medical
  • ProTech Sleep Solutions
SHW 25.03.10

The sleep disorders market size is expected to reach USD 66.55 billion by 2034, according to a new study by Polaris Market Research. The report "Sleep Disorders Market Size, Share, Trends, Industry Analysis Report: By Disorder (Restless Legs Syndrome, Narcolepsy, Insomnia, and Sleep Apnea), Product, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing prevalence of conditions such as insomnia, sleep apnea, and narcolepsy and the growing awareness of the importance of sleep for overall health drive the sleep disorders market demand. Other key drivers include the rising global aging population, high rates of comorbidities such as obesity, and the growing awareness about the negative impacts of poor sleep. Opportunities in the market include the expansion of telemedicine and remote patient monitoring, alongside the adoption of wearable devices and home-based diagnostic tools. Sleep disorders market trends such as the shift toward non-pharmacological treatments, including cognitive behavioral therapy for insomnia (CBT-I), and the integration of AI in sleep management further contribute to market expansion. With these advancements, the market is poised for continued growth, particularly in emerging regions where healthcare access is improving.

Sleep Disorders Market Report Highlights:

The insomnia segment, based on disorder, holds the largest share of the sleep disorders market revenue due to its high prevalence worldwide. However, the sleep apnea segment is expected to register the highest growth rate driven by increasing diagnosis and treatment adoption, particularly with the rising obesity rates.

The diagnostics segment, based on product, dominates the market due to the need for accurate and early detection, while the therapeutics segment is witnessing a higher growth rate, fueled by innovations in CPAP therapy, wearable devices, and non-pharmacological treatments.

By end user, the hospitals & sleep laboratories segment holds a larger share due to their established role in diagnosing and treating complex sleep disorders. On the other side, the home care settings segment is the fastest growing, driven by the increasing demand for convenient, at-home care solutions.

North America leads the sleep disorders market share, driven by advanced healthcare infrastructure and high rates of sleep disorder diagnosis. The market in Asia Pacific is growing the fastest, fueled by improving healthcare access, rising awareness, and an aging population.

Polaris Market Research has segmented the sleep disorders market report on the basis of disorder, product, end user, and region:

By Disorder Outlook (Revenue - USD Billion, 2020-2034)

  • Restless Legs Syndrome
  • Narcolepsy
  • Insomnia
  • Sleep Apnea

By Product Outlook (Revenue - USD Billion, 2020-2034)

  • Diagnostics
  • Therapeutics

By End User Outlook (Revenue - USD Billion, 2020-2034)

  • Hospitals & Sleep Laboratories
  • Home Care Settings

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Source
    • 3.2.1. Primary Source
    • 3.2.2. Secondary Source

4. Global Sleep Disorders Market Insights

  • 4.1. Sleep Disorders Market - Market Snapshot
  • 4.2. Sleep Disorders Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increased Adoption of Telemedicine for Sleep Disorder Diagnosis and Treatment
      • 4.2.1.2. Advancements in Wearable Sleep Monitoring Devices
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Treatment Costs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry Among Existing Firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Sleep Disorders Market Application Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Sleep Disorders Market, by Disorder

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
  • 5.3. Restless Legs Syndrome
    • 5.3.1. Global Sleep Disorders Market, by Restless Legs Syndrome, by Region, 2020-2034 (USD Billion)
  • 5.4. Narcolepsy
    • 5.4.1. Global Sleep Disorders Market, by Narcolepsy, by Region, 2020-2034 (USD Billion)
  • 5.5. Insomnia
    • 5.5.1. Global Sleep Disorders Market, by Insomnia, by Region, 2020-2034 (USD Billion)
  • 5.6. Sleep Apnea
    • 5.6.1. Global Sleep Disorders Market, by Sleep Apnea, by Region, 2020-2034 (USD Billion)

6. Global Sleep Disorders Market, by Product

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
  • 6.3. Diagnostics
    • 6.3.1. Global Sleep Disorders Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
  • 6.4. Therapeutics
    • 6.4.1. Global Sleep Disorders Market, by Therapeutics, by Region, 2020-2034 (USD Billion)

7. Global Sleep Disorders Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 7.3. Hospitals & Sleep Laboratories
    • 7.3.1. Global Sleep Disorders Market, by Hospitals & Sleep Laboratories, by Region, 2020-2034 (USD Billion)
  • 7.4. Home Care Settings
    • 7.4.1. Global Sleep Disorders Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)

8. Global Sleep Disorders Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Sleep Disorders Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Sleep Disorders Market - North America
    • 8.3.1. North America: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.3.2. North America: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.3.3. North America: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.3.4. Sleep Disorders Market - US
      • 8.3.4.1. US: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.3.4.2. US: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.3.4.3. US: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.3.5. Sleep Disorders Market - Canada
      • 8.3.5.1. Canada: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 8.4. Sleep Disorders Market - Europe
    • 8.4.1. Europe: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.4. Sleep Disorders Market - UK
      • 8.4.4.1. UK: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.5. Sleep Disorders Market - France
      • 8.4.5.1. France: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.6. Sleep Disorders Market - Germany
      • 8.4.6.1. Germany: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.7. Sleep Disorders Market - Italy
      • 8.4.7.1. Italy: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.8. Sleep Disorders Market - Spain
      • 8.4.8.1. Spain: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.9. Sleep Disorders Market - Netherlands
      • 8.4.9.1. Netherlands: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.10. Sleep Disorders Market - Russia
      • 8.4.10.1. Russia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.4.11. Sleep Disorders Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 8.5. Sleep Disorders Market - Asia Pacific
    • 8.5.1. Asia Pacific: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.4. Sleep Disorders Market - China
      • 8.5.4.1. China: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.5. Sleep Disorders Market - India
      • 8.5.5.1. India: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.6. Sleep Disorders Market - Malaysia
      • 8.5.6.1. Malaysia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.7. Sleep Disorders Market - Japan
      • 8.5.7.1. Japan: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.8. Sleep Disorders Market - Indonesia
      • 8.5.8.1. Indonesia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.9. Sleep Disorders Market - South Korea
      • 8.5.9.1. South Korea: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.10. Sleep Disorders Market - Australia
      • 8.5.10.1. Australia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.5.11. Sleep Disorders Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 8.6. Sleep Disorders Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.4. Sleep Disorders Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.5. Sleep Disorders Market - UAE
      • 8.6.5.1. UAE: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.6. Sleep Disorders Market - Israel
      • 8.6.6.1. Israel: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.7. Sleep Disorders Market - South Africa
      • 8.6.7.1. South Africa: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.6.8. Sleep Disorders Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
  • 8.7. Sleep Disorders Market - Latin America
    • 8.7.1. Latin America: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.7.4. Sleep Disorders Market - Mexico
      • 8.7.4.1. Mexico: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.7.5. Sleep Disorders Market - Brazil
      • 8.7.5.1. Brazil: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.7.6. Sleep Disorders Market - Argentina
      • 8.7.6.1. Argentina: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)
    • 8.7.7. Sleep Disorders Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Sleep Disorders Market, by Disorder, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Sleep Disorders Market, by Product, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Sleep Disorders Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. ResMed
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Philips Healthcare
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Medtronic
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Fisher & Paykel Healthcare
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Somnomed
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Sleep Number Corporation
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Invacare Corporation
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Nihon Kohden Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. CareFusion
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Becton Dickinson
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Circadia
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Inogen
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Itamar Medical
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. ProTech Sleep Solutions
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제